New Blood Thinning Drug Studied
Posted on: Friday, 8 September 2006, 15:00 CDT
Researchers at the University of Kentucky are studying a blood-thinning drug that may become the standard for use in procedures to unblock cardiac arteries.
Results of the study on the drug enoxaparin appear in the New England Journal of Medicine.
Dr. Steven Steinhubl, senior author of the study and a researcher at the University of Kentucky's Linda and Jack Gill Heart Institute, says enoxaparin was found to carry less risk for bleeding than unfractionated heparin.
While elective stent and angioplasty procedures to clear blocked arteries are generally safe, a small percentage of patients experience significant bleeding.
The Kentucky study found that enoxaparin cut major bleeding by more than half and that doctors were more likely to achieve targeted blood thinning for their patients with enoxaparin than unfractionated heparin.
Bleeding following a stent placement or angioplasty is an event that is not only dangerous for patients, but also carries a financial burden for the healthcare industry as a whole, Steinhubl says.
Source: United Press International
Related Articles
- GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
- Pivotal Phase III Trial Showed PROMACTA(R) (Eltrombopag Olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
- The Medicines Company Supports Landmark Patient Observational Study and Clinical Survey on Acute Severe Hypertension
- SinoFresh Reports Patient Case Study: Allergic Fungal Rhinosinusitis in Adult Male With History of Sinus Conditions
- Medical Management Shifts Focus to High-Risk Patients, URAC Study Finds
- Atherogenic Lipid Profile and Cardiovascular Risk Factors in HIV- Infected Patients (Ntar Study)
- Genentech Stops Enrolling Patients in Study
- ARIXTRA(R) Showed Comparable Efficacy to LOVENOX(R)/CLEXANE(R) With Significantly Less Major Bleeding in Patients With Acute Coronary Syndromes
- Study: Drug Helps Bleeding Stroke Patients
- Trasylol(R) (Aprotinin Injection) Reduced Bleeding in Patients Receiving Anti-Platelet Therapy Prior to Coronary Artery Bypass Graft Surgery
 |
 |
User Comments (0)
RSS Feeds